ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Antimicrobial Susceptibility Testing Market Size to Reach USD 4.70 Billion by 2030, Driven by Rising Antimicrobial Resistance and Growing Focus on Accurate Diagnostics

Mordor Intelligence has published a new report on the Antimicrobial Susceptibility Testing Market, offering a comprehensive analysis of trends, growth drivers, and future projections.

-- Introduction to Antimicrobial Susceptibility Testing Market Size 

The Antimicrobial Susceptibility Testing Market Size is estimated at USD 4.70 billion in 2025 and is forecast to reach USD 6.21 billion by 2030, growing at a CAGR of 5.73% during the period, according to Mordor Intelligence. 

Antimicrobial susceptibility testing (AST) plays a vital role in identifying the appropriate antimicrobial therapy for bacterial and fungal infections. With the rise of antimicrobial resistance (AMR) across the globe, laboratories and healthcare institutions are increasingly adopting advanced testing methods to improve diagnostic accuracy and patient outcomes. 

The global rise in infectious diseases, coupled with regulatory initiatives to promote better antimicrobial stewardship, is further boosting the adoption of AST. The demand is particularly high in clinical diagnostics, pharmaceutical research, and biotechnology applications, where precise microbial testing is essential. 

Key Trends in the Antimicrobial Susceptibility Testing Market Trends 

The Antimicrobial Susceptibility Testing Market Trends indicate strong growth driven by rising awareness about AMR and the expanding role of molecular diagnostics. Key developments include: 

  • Rising Burden of Antimicrobial Resistance (AMR) 
  • The increasing prevalence of resistant infections is a major driver of market demand. Healthcare providers are emphasizing AST to ensure effective treatment regimens and to combat the public health threat of drug-resistant pathogens. 
  • Shift Toward Automated Testing Systems 
  • Clinical laboratories are increasingly using automated AST systems that offer faster and more accurate results. This trend is helping reduce manual workload and supporting timely patient management. 
  • Integration of Molecular Diagnostics in AST 
  • Molecular techniques are gaining traction as they allow for rapid detection of resistance genes. This trend is enhancing the precision of AST and complementing traditional culture-based methods. 
  • Growing Use in Pharmaceutical and Biotechnology Research 
  • Beyond clinical applications, AST is being used in drug discovery and development to test the efficacy of new antibiotics and monitor resistance patterns. This is creating new avenues for growth in the Antimicrobial Susceptibility Testing Industry

Check out more details on the Antimicrobial Susceptibility Testing Market and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/antimicrobial-susceptibility-testing-market?utm_source=marketersmedia 

Market Segmentation of the Antimicrobial Susceptibility Testing Industry 

The Antimicrobial Susceptibility Testing Market Share is segmented by product type, application, end user, and geography. Each segment reflects unique demand patterns and growth opportunities: 

  • By Product Type 
  • Manual AST Testing Products 
  • Automated AST Testing Products 
  • Consumables & Media 
  • By Application 
  • Clinical Diagnostics 
  • Drug Discovery and Development 
  • Other Applications 
  • By End User 
  • Hospitals and Diagnostic Laboratories 
  • Pharmaceutical and Biotechnology Companies 
  • Research and Academic Institutes 
  • By Geography 
  • North America 
  • Europe 
  • Asia-Pacific 
  • Middle East & Africa 
  • South America 

Among these, automated AST systems are gaining significant traction due to their speed and accuracy, while clinical diagnostics remains the largest application segment. Regionally, North America holds a considerable Antimicrobial Susceptibility Testing Market Share due to advanced healthcare infrastructure, while Asia-Pacific is expected to see rapid growth as healthcare systems expand and awareness of AMR increases. 

Key Players in the Antimicrobial Susceptibility Testing Market

The Market is competitive, with global and regional companies focusing on expanding product portfolios and enhancing technological capabilities. Key players include: 

  • bioMérieux SA 
  • Becton Dickinson, and Company 
  • Thermo Fisher Scientific Inc. 
  • Bio-Rad Laboratories, Inc. 
  • Danaher Corporation 

These companies are engaged in research and development to bring advanced solutions that improve diagnostic accuracy, reduce turnaround times, and support laboratories in managing resistant infections. Their strategic initiatives include partnerships, acquisitions, and regulatory approvals to strengthen their market presence. 

Explore more insights on antimicrobial susceptibility testing market competitive landscape: https://www.mordorintelligence.com/industry-reports/antimicrobial-susceptibility-testing-market/companies?utm_source=marketersmedia

Conclusion: Outlook for the Antimicrobial Susceptibility Testing Market Growth 

The Antimicrobial Susceptibility Testing Market Growth outlook remains strong as global healthcare systems prioritize effective infection management and antibiotic stewardship. With rising AMR posing a critical health challenge, AST is becoming a cornerstone of clinical diagnostics and research. 

The Antimicrobial Susceptibility Testing Industry is poised not only to support clinicians in delivering better patient care but also to aid pharmaceutical and biotechnology firms in developing new antibiotics and tackling emerging resistance trends. Its growth trajectory indicates that AST will remain central to the future of infectious disease management. 

Industry Related Reports 

Veterinary Antimicrobial Susceptibility Testing Market: The Veterinary Antimicrobial Susceptibility Testing Market Report is Segmented by Product Type (Disks & Plates, Culture Media, Automated Testing Systems, Other Products), Testing Method (Disk Diffusion, Broth Micro-Dilution, and More), Animal Type (Companion Animals, Livestock), End User (Veterinary Reference Labs, and More), and Geography (North America, Europe, and More). 

Get more insights: https://www.mordorintelligence.com/industry-reports/antimicrobial-susceptibility-testing-market/companies?utm_source=marketersmedia

Antimicrobial Resistance Surveillance Market: The Antimicrobial Resistance Surveillance Market Report is Segmented by Solution (Kits, Systems, and More), Technology (Culture-Based Methods, and More), Application (Clinical Diagnostics, Public-Health Surveillance, and More), End-User (Hospitals and Clinics, Diagnostic Laboratories, Other End-Users), and Geography (North America, and More). 

Get more insights: https://www.mordorintelligence.com/industry-reports/antimicrobial-susceptibility-testing-market/companies?utm_source=marketersmedia

Rapid Microbiology Testing Market: The Rapid Microbiology Testing Market Report is Segmented by Product Type (Consumables, Instruments, and Reagents & Kits), Method (Cellular Component-Based Methods, and More), Application (Clinical Diagnostics, and More), End User (Clinical Laboratories, and More), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, South America). 

Get more insights: https://www.mordorintelligence.com/industry-reports/antimicrobial-susceptibility-testing-market/companies?utm_source=marketersmedia

About Mordor Intelligence:   

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.   

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.    

For any inquiries or to access the full report, please contact:  

media@mordorintelligence.com 

https://www.mordorintelligence.com/ 

About the company: Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. For any inquiries or to access the full report, please contact: media@mordorintelligence.com https://www.mordorintelligence.com/

Contact Info:
Name: Jignesh Thakkar
Email: Send Email
Organization: Mordor Intelligence
Address: Hyderabad
Phone: +1617-765-2493
Website: https://www.mordorintelligence.com/

Release ID: 89169315

In the event of encountering any errors, concerns, or inconsistencies within the content shared in this press release, we kindly request that you immediately contact us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your feedback within 8 hours and take appropriate measures to rectify any identified issues or facilitate press release takedowns. Ensuring accuracy and reliability are central to our commitment.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.